Related Experiment Videos
[Prescribing beta blockers in elderly patients with heart failure]
Michel Galinier1, Jean-Paul Emeriau
1Pôle cardiovasculaire et métabolique, CHU de Toulouse, Hôpital Rangueil TSA 50032, F-31509 Toulouse Cedex 9, France. galinier.m@chu-toulouse.fr
Presse Medicale (Paris, France : 1983)
|May 3, 2008
Summary
Beta blockers are safe and effective for elderly heart failure patients, regardless of ejection fraction. Careful titration and monitoring are essential for optimal outcomes in this population.
Area of Science:
- Cardiology
- Geriatrics
- Pharmacology
Context:
- Beta-blocker therapy is underutilized in elderly heart failure patients.
- Age alone is not a contraindication for beta-blocker use.
- The SENIORS study provides evidence for efficacy and tolerability in this demographic.
Purpose:
- To highlight the efficacy and tolerability of beta blockers in elderly heart failure patients.
- To provide guidance on initiating and titrating beta-blocker therapy in older adults.
- To emphasize the importance of strict adherence to prescription protocols.
Summary:
- Beta blockers are effective and well-tolerated in elderly patients with heart failure, irrespective of ejection fraction.
- Initiate treatment in stable NYHA class II-III patients at least one month post-decompensation.
- Employ low initial doses (1.25 mg/d) and very gradual titration to target doses (10 mg/d), adjusting other antihypertensives and diuretics as needed.
Impact:
- Optimizing beta-blocker use can improve outcomes for elderly heart failure patients.
- Adherence to specific dosing protocols can mitigate risks and enhance treatment benefits.
- This approach supports evidence-based management of heart failure in geriatric populations.
Related Concept Videos
01:22Heart Failure Drugs: β-Blockers
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
01:27Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in bronchial smooth...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:28Antihypertensive Drugs: Types of β-Blockers
β receptors are classified into three subclasses: β1, β2, and β3. β1 receptors are primarily located in the heart and kidneys. When they get activated, they increase heart rate, contractility, and renin release. This process enhances blood pressure and aids in stress management. In contrast, β2 receptors are situated mainly in the lungs, blood vessels, and skeletal muscles. Upon activation, they trigger smooth muscle relaxation, causing bronchodilation and vasodilation. This widens airways and...
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...